At AseBio we want to put biotechnology at the heart of our country's recovery strategy, to drive the green transition of our economy and to strengthen our National Health System
#InterviewBiospain2021 | "Biospain should be an inspiring event that motivates emerging bi...
We spoke with Karen Wagner, General Partner of Ysios Capital, Gold sponsor de Biospain 2021, about our international...
#InterviewBiospain2021 | Asabys, leading Spanish health investor accredited for its commit...
We spoke with Clara Campàs and Josep Lluís Sanfeliu, founders of Asabys Partners venture capital, silver sponsor of...
#InterviewBiospain2021 | The company born drinking a beer that ended up as the first to de...
3P Biopharmaceuticals operates globally, with 19 active projects worldwide and has positioned itself, after a difficult...
Personalised medicine increases its activity by 40% in the last year and is becoming more ...
Precision medicine and personalised medicine products or services have gone from representing 12% of total launches to...
Ysios Capital achieves Certification under the Diversity VC Standard
Ysios Capital is the first specialized venture capital firm in life sciences globally and the first Spanish firm to...
Whole Genome Sequencing :The Future Is Now
What was once only a futuristic vision has become reality for patients and physicians seeking answers for a rare disease...
ORYZON reports results and corporate update for first half ended June 30, 2021
Oryzon Genomics, S.A., the Spanish company developing innovative epigenetic experimental therapies, announces results...
The biotech sector is global and internationalization a key axis of the development of its companies. AseBio promotes major events, such as BioSpain, and since 2008 manages the 'ICEX Internationalization Plan for biotechnology companies'. Discover what we can offer you.
